RESULTS
Table 1 presents the Phase 5 distribution of self reported
health, minor psychiatric morbidity, physiological measures,
and health related behaviours for control participants
(continued secure employment) and participants in the three
exposure groups: insecure at Phase 4 and secure at Phase 5;
secure at Phase 4 and insecure at Phase 5; and insecure at both
phases. The effects of these exposures on self reported health,
minor psychiatric morbidity, physiological measures, and
health related behaviours at Phase 5, relative to outcomes for
control participants are presented in table 2. Analyses
adjusted for negative affect produced results similar to those
presented in table 2 (data not shown).